Recipharm Acquisitions

Recipharm has acquired 12 companies and its latest acquisition was GenIbet Biopharmaceuticals SA on Feb 2022

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
GenIbet Biopharmaceuticals SA

Feb 2022

Source »
undisclosed
GenIbet is a Portugal-based contract development and manufacturing organization that offers services such as quality control and process development for the biotech industry.
Arranta Bio, LLC

Feb 2022

Source »
undisclosed
Arranta Bio is a Massachusetts-based CDMO that provides services such as mRNA vaccine and microbiome LBP manufacturing for the pharmaceutical industry.
Consort Medical Plc

Nov 2019

Source »
$649M
Consort Medical is a contract developer and manufacturer of drug delivery devices that include nasal inhalers and pharmaceutical compounds.

-

Sanofi CMO Business, Sanofi S.A.

Jun 2018

Source »
$60.1M
-

-

Pharmaceutical Businesses, Kemwell

Feb 2017

Source »
$118.5M
-

Frequently Asked Questions about Recipharm

  1. What companies did Recipharm acquire?

    Companies acquired by Recipharm include GenIbet, Arranta Bio and Consort Medical
  2. How many acquisitions does Recipharm have?

    Recipharm has acquired 12 companies including GenIbet, Arranta Bio and Consort Medical.
  1. How many acquisitions did Recipharm make in 2022?

    In 2022 Recipharm acquired 2 companies including GenIbet and Arranta Bio.